ProfileGDS4718 / 205184_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 54% 48% 59% 58% 48% 81% 76% 65% 48% 51% 45% 54% 53% 89% 80% 56% 47% 52% 54% 71% 48% 55% 38% 42% 57% 79% 52% 90% 50% 75% 55% 85% 51% 44% 86% 90% 93% 55% 58% 66% 57% 76% 72% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.7808854
GSM549102patient 115, normal, homogenized [OPG study]5.3993748
GSM549104patient 119, normal, homogenized [OPG study]6.0439859
GSM549108patient 138, normal, homogenized [OPG study]5.9895558
GSM549119patient 077, normal, homogenized [OPG study]5.4110248
GSM549133patient 032, cancer, homogenized [OPG study]8.0889581
GSM549139patient 042, cancer, homogenized [OPG study]7.4173676
GSM549099patient 107, normal, homogenized [OPG study]6.4220765
GSM549109patient 139, normal, homogenized [OPG study]5.4061548
GSM549110patient 046, normal, homogenized [OPG study]5.5709551
GSM549114patient 063, normal, homogenized [OPG study]5.2185345
GSM549122patient 082, normal, homogenized [OPG study]5.7601454
GSM549134patient 033, cancer, homogenized [OPG study]5.6443553
GSM549136patient 036, cancer, homogenized [OPG study]9.1189389
GSM549140patient 044, cancer, homogenized [OPG study]7.9431380
GSM549111patient 047, normal, homogenized [OPG study]5.8637256
GSM549113patient 057, normal, homogenized [OPG study]5.2656647
GSM549132patient 031, cancer, homogenized [OPG study]5.6470552
GSM549137patient 038, cancer, homogenized [OPG study]5.7119754
GSM549142patient 047, cancer, homogenized [OPG study]6.9333471
GSM549100patient 110, normal, homogenized [OPG study]5.4061248
GSM549107patient 135, normal, homogenized [OPG study]5.7542155
GSM549115patient 068, normal, homogenized [OPG study]4.8422538
GSM549116patient 072, normal, homogenized [OPG study]5.0634342
GSM549120patient 078, normal, homogenized [OPG study]5.9047757
GSM549131patient 030, cancer, homogenized [OPG study]7.8307379
GSM549118patient 074, normal, homogenized [OPG study]5.6083152
GSM549129patient 027, cancer, homogenized [OPG study]9.141290
GSM549123patient 088, normal, homogenized [OPG study]5.4787550
GSM549124patient 006, cancer, homogenized [OPG study]7.3153575
GSM549126patient 015, cancer, homogenized [OPG study]5.7816255
GSM549128patient 025, cancer, homogenized [OPG study]8.5439485
GSM549103patient 117, normal, homogenized [OPG study]5.6149151
GSM549117patient 073, normal, homogenized [OPG study]5.1772844
GSM549138patient 041, cancer, homogenized [OPG study]8.6672286
GSM549141patient 045, cancer, homogenized [OPG study]9.3004990
GSM549130patient 028, cancer, homogenized [OPG study]9.5348793
GSM549101patient 111, normal, homogenized [OPG study]5.8059755
GSM549105patient 128, normal, homogenized [OPG study]5.9771858
GSM549106patient 134, normal, homogenized [OPG study]6.5720266
GSM549112patient 048, normal, homogenized [OPG study]5.9378757
GSM549125patient 011, cancer, homogenized [OPG study]7.390876
GSM549127patient 024, cancer, homogenized [OPG study]7.1170672
GSM549135patient 035, cancer, homogenized [OPG study]9.1788589